Approved by the Food & Drug Administration (FDA) in 1982, Accutane has been the subject of controversy for years. It first garnered attention in the late eighties for causing severe birth defects. It has also been known to cause psychiatric problems, and has been linked to hundreds of cases of suicide in the United States. It was recently announced on October 4th that Accutane lawsuits had just reached 6,384 cases. This means there has been an addition of nearly 1,200 cases since August. The spike in Accutane claims filed in New Jersey comes on the heels of a court ruling there that found the statute of limitation for such lawsuit should be based on when plaintiffs discovered there could be a connection between the Accutane and their bowel disorder.
All of the suits involve allegations that side effects of Accutane, a popular acne medication developed by Roche, caused users to develop severe gastrointestinal problems. Plaintiffs allege that Roche and generic drug makers failed to adequately research the medication or warn about the risk of inflammatory bowel disease, which could include Accutane ulcerative colitis and Crohn’s disease.